Abecma Suspension
Product Images NDC 59572-515

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Abecma (NDC 59572-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celgene Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Abecma 01)

Label from a cellular therapy suspension product named Abecma (idecabtagene vicleucel) by Celgene Corporation with NDC 59572-515. The label includes patient-specific information fields such as Patient Name, Date of Birth, Patient DIN or Aph ID, JOIN, Lot number, Bag ID, and Expiration date, along with a QR code.*

FDA Label Image

Principal Display Panel (30 mL Bag Label)

Label for Abecma (idecabtagene vicleucel) suspension for intravenous infusion, manufactured by Celgene Corporation. The label includes dosing volume (10-30 mL per bag), handling instructions such as storage in vapor phase liquid nitrogen, and a warning not to use a leukodepleting filter or irradiation. It also notes the product contains CAR-positive T cells and is preservative free. Contact and licensing information for Celgene Corporation is provided.*

FDA Label Image

Principal Display Panel (30 mL Cassette Label)

Label for Abecma (idecabtagene vicleucel) cellular therapy suspension for intravenous infusion by Celgene Corporation. The label includes dosage instructions, volume range (10mL - 30mL per bag), storage conditions (vapor phase of liquid nitrogen at -130°C or below), and manufacturer contact information. It also notes the product is genetically modified autologous T cells and is prescription only (Rx Only).*

FDA Label Image

Principal Display Panel (70 mL Bag Label)

Label for Abecma (idecabtagene vicleucel) suspension for intravenous infusion by Celgene Corporation. It specifies the product as genetically modified autologous T cells for autologous and intravenous use only. The label includes acceptable infusion volumes, dosage note, cell count range, storage instructions in vapor phase liquid nitrogen, and a QR code with barcode area.*

FDA Label Image

Principal Display Panel (70 mL Cassette Label)

Abecma idecabtagene vicleucel suspension for intravenous infusion, manufactured by Celgene Corporation. The label indicates this genetically modified autologous T cell therapy is supplied in volumes of 30 to 70 mL per bag with a strength of 300000000 cells. It includes storage instructions and manufacturer contact details, with NDC 59572-515-02 shown.*

FDA Label Image

Principal Display Panel (100 mL Bag Label)

Abecma (idecabtagene vicleucel) suspension for intravenous infusion by Celgene Corporation. The label indicates a genetically modified autologous T cell product with a volume of 55-100 mL per bag. It contains 300 to 460 x 10^6 anti-BCMA02 CAR-positive T cells in a cryopreservative solution. Instructions include storage in vapor phase of liquid nitrogen and warning not to use a leukodepleting filter or irradiate. The label also includes manufacturer contact information and placeholders for patient-specific details.*

FDA Label Image

Principal Display Panel (100 mL Cassette Label)

Label for Abecma (idecabtagene vicleucel) suspension for intravenous infusion. The label states it is genetically modified autologous T cells for autologous and intravenous use only. The product is manufactured by Celgene Corporation, a Bristol-Myers Squibb Company, and includes details on acceptable volume, dosage reference, storage conditions, and warnings. It also contains placeholders for patient information, lot number, and expiration date. The NDC is 59572-515-03.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.